The Union Health Ministry on Sunday revised guidelines mandating that all international passengers entering India have to submit 14-day travel details and upload a negative RT-PCR test report on the Air Suvidha portal before the journey. The new guidelines will come into effect from December 1.
The RT-PCR report to be uploaded should have been conducted within 72 hours prior to the journey.
Travellers from “countries at-risk”, including the U.K., South Africa, Brazil, Bangladesh, Botswana, China, Mauritius, New Zealand, Zimbabwe, Singapore, Hong Kong and Israel, will need to take the COVID test post-arrival and wait for results at the airport, according to the guidelines. If tested negative, they have to undergo home quarantine for seven days followed by a re-test on the eighth day.
“On arrival, the passengers found to be symptomatic during screening shall be immediately isolated and taken to medical facility as per health protocol. If tested positive, their contacts shall be identified and managed as per laid down protocol,” said the updated guidelines.
Travellers from countries not considered ‘at risk’ will be allowed to leave the airport and must self-monitor their health for 14 days post arrival. A sub-section (5% of the total flight passengers) will be required to undergo post-arrival testing at random at the airport.
The guidelines have also stated that children under five years of age are exempted from pre- and post-arrival testing. However, if found symptomatic on arrival or during home quarantine, they shall undergo testing and treated as per protocol.
Contacts of the suspect case are the co-passengers seated in the same row, three rows in front and three rows behind along with identified cabin crew. Also, all the community contacts of those travellers who have tested positive (during home quarantine period) would be subjected to quarantine for 14 days and tested as per government protocol.
Earlier the Central Government in a release issued following a meeting chaired by Home Secretary Ajay Bhalla, said it will review “the decision on effective date of resumption of scheduled commercial international passengers service as per evolving global scenario while keeping a closer watch on emerging pandemic situation within the country.”
The meeting held to review the global situation in wake of Omicron virus was attendant by various domain experts including Dr. V K Paul, Member (Health) NITI Aayog, Dr. Vijay Raghavan, Principal Scientific Adviser to Prime Minister and senior officers from Health, Civil Aviation and other Ministries.
It has also been decided that Airport Health Officials (APHOs) and Port Health Officials (PHOs) will be sensitized for strict supervision of testing protocol at airports/ ports, added the release.
Also read | Coronavirus: What are variants of concern?
``Various preventive measures in place and those to be further strengthened were discussed besides reviewing the update of Standard Operating Procedure on testing and surveillance of incoming international passengers, especially for those countries identified ‘at risk’ category. The strengthening and intensification of genomic surveillance for variants through the INSACOG network was agreed upon with a focus on sampling and whole genome sequencing of international passengers especially from those countries where Omicron variant has been detected,’’ added the release.
At meeting the criticality of scrupulous implementation and rigorous monitoring of the three-pronged surveillance strategy of screening and testing international travelers and their contacts, routine sentinel surveillance and surge surveillance, and timely sending of RT- PCR positive samples to designated INSACOG Genome Sequencing Laboratories (IGSLs) were stressed upon along with enhanced testing and monitoring of COVID-19 hotspots.
Earlier on Saturday Prime Minister Narendra Modi chaired a high-level meeting to review the emerging situation and India's preparedness in terms of public health measures. The Health Ministry too has advised States/UTs regarding testing, surveillance, monitoring of hotspots, augmentation of health infrastructure, genome sequencing, and enhancing public awareness.